2 years ago
NVAX
AnalystsBrendan SmithBrendan Smith's Stock Forecasts
AnalystsBrendan Smith
Analyst Ranking
Top 50%
#2586 out of 5209 analysts
Average Return
+1.1%
Win Rate
40%4 out of 10
Risk vs Reward
Poor
Good
Brendan Smith's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Halozyme Therapeutics IncHALO | +44.94% | $39.81 | $57.70 | 2024-02-28 - 2025-02-27 | Buy |
Ginkgo Bioworks Holdings IncDNA | +41.95% | $8.01 | $11.37 | 2024-09-19 - 2025-09-19 | Strong Buy |
Twist Bioscience CorpTWST | +38.34% | $34.74 | $48.06 | 2026-01-07 - 2026-03-04 | Strong Buy |
Halozyme Therapeutics IncHALO | +15.15% | $54.12 | $62.32 | 2024-08-07 - 2025-08-06 | Strong Buy |
Brendan Smith Analyst Color
Get additional color on Brendan Smith's coverage of popular stocks
Brendan Smith's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ginkgo Bioworks Holdings IncDNA | 2 | Strong Buy | $12.00 | +79.37% | Maintains | 2 months ago |
Twist Bioscience CorpTWST | 1 | Strong Buy | $43.00 | -10.53% | Maintains | 2 months ago |
Simulations Plus IncSLP | 2 | Hold | $19.00 | +53.85% | Maintains | 2 months ago |
Schrodinger IncSDGR | 1 | Strong Buy | $24.00 | +82.93% | Maintains | 2 months ago |
Cytek Biosciences IncCTKB | 1 | Strong Buy | $5.00 | +13.38% | Maintains | 2 months ago |
Azenta IncAZTA | 1 | Hold | $39.00 | +55.19% | Maintains | 2 months ago |
Halozyme Therapeutics IncHALO | 3 | Strong Buy | $90.00 | +28.53% | Maintains | 2 months ago |
Novavax IncNVAX | 2 | Hold | $7.00 | -29.22% | Maintains | 4 months ago |
West Pharmaceutical Services IncWST | 1 | Strong Buy | $350.00 | +40.65% | Initiates Coverage On | 4 months ago |
Denali Therapeutics IncDNLI | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.